BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 16, 2023
Data Byte

Translational spotlight on variant-proofing tech for COVID and beyond

Host targets and antiviral strategies with efficacy across multiple viruses in BioCentury’s Distillery
Read More
BioCentury | Dec 31, 2020
Distillery Therapeutics

Host-directed inhibitors against the SKI complex to inhibit coronavirus, influenza, Ebola, Marburg viruses

DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus; influenza virus; Ebola; infectious Host-directed therapies inhibiting SKI complex components SKIV2L, TTC37 and WDR61 could treat
Read More
Items per page:
1 - 2 of 2